Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PD-1 CAR NK-92 CELL AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/076391
Kind Code:
A1
Abstract:
Provided are a PD-1 CAR NK-92 cell and a preparation method therefor and the use thereof. The PD-1 CAR NK-92 cell expresses a PD-1-CD8TM-4-1BB-CD3 ζ fusion protein in NK-92 cells. The PD-1 CAR NK-92 is obtained by infecting an NK92 cell strain with a PD-1 CAR molecule and obtaining monoclonal cells by means of flow screening, and culturing and amplifying CAR NK92 monoclonal cell strains with stable traits and a high killing activity. The cell can be used in large-scale production and manufacture, can be used for different patients and does not produce GVHR rejection. The killing activity thereof is specific, and the therapeutic effects on tumours are evident.

Inventors:
LI HUASHUN (CN)
WANG BAOLEI (CN)
HAN KUNKUN (CN)
REN BAOYONG (CN)
Application Number:
PCT/CN2016/104493
Publication Date:
May 03, 2018
Filing Date:
November 04, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LI HUASHUN (CN)
International Classes:
C12N5/10; A61K35/17; A61K48/00; A61P35/00; C07K19/00; C12N7/01; C12N15/62; C12N15/86
Domestic Patent References:
WO2015142675A22015-09-24
WO2015090229A12015-06-25
Foreign References:
CN105392888A2016-03-09
CN105132445A2015-12-09
CN104114233A2014-10-22
Other References:
CAMPBELL, K. S. ET AL.: "Natural killer cell biology: An update and future directions", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 132, no. 3, 30 July 2013 (2013-07-30), pages 536 - 544, XP055145468
GUO, ZHENHONG ET AL.: "The current situation and prospect of immunocyte-therapy for tumor", CHINESE JOURNAL OF CANCER BIOTHERAPY, vol. 23, no. 2, 30 April 2016 (2016-04-30), pages 149 - 160
Attorney, Agent or Firm:
BRIGHTHEAD INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: